Description: This session will discuss the regulatory environment for life and annuity products. The ever-changing landscape of the regulatory environment makes life and annuity product development and management more complicated. Federal developments, including the DOL fiduciary rule and Algorithmic accountability, as well as State developments such as AI and challenges to underwriting are just a few of the topics covered in this session.

Description: The session will discuss key areas of statutory reserving that contain some ambiguity or areas where there are simplifications being used in the industry. The content will be based on current practices used in the industry and possibly accompanied by an industry survey to be completed prior to the session. The focus will be heavily on CRVM, AG38, and PBR statutory frameworks and will include a Q&A portion for audience participation. Some potential topics will be reinsurance modeling, DBO3/ROP treatment, segmentation, deficiency reserves, system differences and multi-tiered designs

Description: This session will review reinsurance fundamentals, risk assessment techniques, optimization strategies, and regulatory considerations through case studies and best practices. Attendees will gain insights into enhancing capital management, risk mitigation, and improving operating results, utilizing practical insights from both reinsurers and direct experience. This presentation offers a valuable and practical opportunity to navigate the complexities of reinsurance, optimize transactions, and driving strategic growth in today's dynamic insurance landscape.

Description: Insurers have long relied on scenario analysis to understand the long-term impacts of potential business decisions, but the advent of rapidly changing market environments and a growing desire to optimize capital has spurred business leaders to leverage new tools in order to explore potential options.

Description: The Individual Life Experience Committee has completed their latest report on intercompany mortality experience by amount of insurance under standard individually underwritten issues. This includes study years 2009-2015.

Description: The Reinsurance Section, Product Development Section and the Committee on Life Insurance Research are pleased to present results from a company practice survey of individual life insurance accelerated underwriting. Performed by a Milliman team led by Al Klein and Karen Rudolph, the study provides perspectives from both direct life insurance companies and reinsurers. Among the areas addressed include the structure of accelerated underwriting programs, how programs are monitored, how accelerated underwritten business is performing relative to expectations and how companies are considering accelerated underwriting cohorts in the context of VM-20 assumption setting.

Description: The primary purposes of the study are the following: 1. Compare recent industry experience for individual life waiver of premium (ILWOP) insurance products to the claim incidence and claim termination rates from the 1952 SOA Disability Table; 2. Analyze actual-to-expected (A/E) claim incidence and claim termination ratios across key segments such as gender, attained age, etc.; 3. Develop an illustrative experience basis for calculating policy and claim reserves based on the results from the A/E studies; and 4. Compare reserves calculated using experience assumptions to the reserves calculated using the 1952 SOA Disability Table for an illustrative cohort of ILWOP business.

Description: This report provides various summaries of the above listed data and provides observations from these summaries, with a goal to help actuaries understand the emerging trends in mortality due to COVID-19.

Description: This study estimates the number of COVID-19 confirmed cases and reported deaths by hospital referral regions (HRR) using Johns Hopkins University COVID-19 data by U.S. county and the Dartmouth Atlas Project division of counties into HRRs.

Description: The Mortality Improvement Model, MIM-2021- V3. Different mortality projection methodologies are utilized by actuaries across applications and practice areas. As a result, the MIM Advisory Group (“Advisory Group”) developed a single framework to serve as a consistent base for practitioners in projecting mortality improvement.